期刊文献+

Effect of surfactant protein A on lipopolysaccharide-induced tumor necrosis factor-α expression in human proximal tubular epithelial cells 被引量:2

Effect of surfactant protein A on lipopolysaccharide-induced tumor necrosis factor-α expression in human proximal tubular epithelial cells
原文传递
导出
摘要 Background Surfactant protein A (SP-A) contributes to the regulation of sepsis-induced acute lung injury.In a previous study,we demonstrated the expression and localization of SP-A in the kidneys.The present study evaluated the effect of SP-A on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) expression and its underlying mechanisms in the human renal tubular epithelial (HK-2) cells.Methods Indirect immunofiuorescence assay was used to detect SP-A distribution and expression in HK-2 cells.HK-2 cells were treated with various concentrations of LPS (0,0.1,1,2,5,and 10 mg/L) for 8 hours and with 5 mg/L LPS for different times (0,2,4,8,16,and 24 hours) to determine the effects of LPS on SP-A and TNF-α expression.Then,HK-2 cells were transfected with SP-A siRNA to analyze nuclear factor κB (NF-κB) P65 and TNF-α expression of HK-2 cells after LPS-treatment.Results Indirect immunofluorescence assay revealed that SP-A is localized to the membrane and cytoplasm of HK-2 cells.Interestingly,SP-A1/SP-A2 and TNF-α expression were found to be significantly increased in HK-2 cells upon LPS treatment.Transfection of LPS-treated HK-2 cells with SP-A siRNA resulted in significant increases in the levels of NF-κB P65 protein and TNF-α mRNA and protein compared to those in non-transfected LPS-treated HK-2 cells.Conclusion SP-A plays an important role in protecting cells against sepsis-induced acute kidney injury by inhibiting NF-κB activity to modulate LPS-induced increase in TNF-α expression. Background Surfactant protein A (SP-A) contributes to the regulation of sepsis-induced acute lung injury.In a previous study,we demonstrated the expression and localization of SP-A in the kidneys.The present study evaluated the effect of SP-A on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) expression and its underlying mechanisms in the human renal tubular epithelial (HK-2) cells.Methods Indirect immunofiuorescence assay was used to detect SP-A distribution and expression in HK-2 cells.HK-2 cells were treated with various concentrations of LPS (0,0.1,1,2,5,and 10 mg/L) for 8 hours and with 5 mg/L LPS for different times (0,2,4,8,16,and 24 hours) to determine the effects of LPS on SP-A and TNF-α expression.Then,HK-2 cells were transfected with SP-A siRNA to analyze nuclear factor κB (NF-κB) P65 and TNF-α expression of HK-2 cells after LPS-treatment.Results Indirect immunofluorescence assay revealed that SP-A is localized to the membrane and cytoplasm of HK-2 cells.Interestingly,SP-A1/SP-A2 and TNF-α expression were found to be significantly increased in HK-2 cells upon LPS treatment.Transfection of LPS-treated HK-2 cells with SP-A siRNA resulted in significant increases in the levels of NF-κB P65 protein and TNF-α mRNA and protein compared to those in non-transfected LPS-treated HK-2 cells.Conclusion SP-A plays an important role in protecting cells against sepsis-induced acute kidney injury by inhibiting NF-κB activity to modulate LPS-induced increase in TNF-α expression.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第2期343-347,共5页 中华医学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China (No. 81201457 and 81070556).
关键词 SEPSIS acute kidney injury surfactant protein A tumor necrosis factor-α LIPOPOLYSACCHARIDE sepsis acute kidney injury surfactant protein A tumor necrosis factor-α lipopolysaccharide
  • 相关文献

参考文献4

二级参考文献41

  • 1Xin-Da Zhou From the Liver Cancer Institute, Zhong Shan Hospital, Fudan University Medical Center, Shanghai 200032, China.Recurrence and metastasis of hepatocellular carcinoma: progress and prospects[J].Hepatobiliary & Pancreatic Diseases International,2002,1(1):35-41. 被引量:22
  • 2樊嘉,徐泱,周俭.肝癌患者肝移植适应证的选择[J].中华医学杂志,2005,85(24):1662-1664. 被引量:23
  • 3Jie Shao Lai Wei Hao Wang Yan Sun Lan-Fang Zhang Jing Li Jian-Qiang Dong.Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B[J].World Journal of Gastroenterology,2007,13(14):2104-2107. 被引量:35
  • 4Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in Advanced Hepatocellular Carcinoma. N Engl J Med, 2008,359: 378-390.
  • 5Saab S, McTigue M, Finn RS, Busuttil RW, et al. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients : feasibility and efficacy. Exp Clin Transplant, 2010,8:307-313.
  • 6L Yoon DH, Ryoo BY, Ryu MH, et al. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Jpn J Clin Oncol, 2010,40:768-773.
  • 7Strumberg D, Voliotis D, Moeller JG, et al. Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors. Int J Clin Pharmacol Ther, 2002,40 : 580-581.
  • 8Fursue J, Ishii H, Nakachi K, et al. Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma. Cancer Sci, 2008,99 : 159-165.
  • 9Abou-Alfa GK, Amadori D, Santom A, et al. Is sorafenib safe and effective in patients with hepatocellular carcinoma and Child- Pugh B cirrhosis?. Clin Oncol, 2008,26 Suppl: 4518.
  • 10Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomized, double-blind, placebo-controlled trial. Lancet Oncol, 2009,10 : 25-34.

共引文献32

同被引文献3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部